Department of Obstetrics, The Fourth People's Hospital of Jinan City, Jinan, Shandong Province, China.
Department of Integrated Treatment Area 1, Affiliated Jinan Third Hospital of Jining Medical University, Jining Medical University, Jinan, Shandong Province, China.
BJOG. 2020 Aug;127(9):1066-1073. doi: 10.1111/1471-0528.16260. Epub 2020 May 12.
Cholera has harmful effects on the fetus but safety data on the oral cholera vaccine in pregnant women are controversial.
We conducted the first meta-analysis of studies in pregnant women comparing the effect of oral cholera vaccination on pregnancy outcomes with unvaccinated women. Outcomes of interest were adverse pregnancy outcome, miscarriage, stillbirth, preterm delivery, low birthweight, abortion and malformation.
The search was run in MEDLINE/PubMed, SCOPUS and Embase databases from inception up to December 2019.
Inclusion criteria were: (1) studies that investigated the association between oral cholera vaccines and adverse pregnancy outcomes; (2) studies that reported outcomes with appropriate estimates; and (3) studies that contained an unvaccinated control group.
A random-effects model (DerSimonian and Laird) was run to evaluate the overall treatment effect (relative risk, RR). The PRISMA statement was followed in reporting this meta-analysis.
Five studies included in meta-analysis with 5584 women (2920 exposed and 2664 not exposed). No significant increase in adverse pregnancy outcome (RR 1.03, 95% CI 0.79-1.34), miscarriage (RR 1.15, 95% CI 0.84-1.57) or stillbirth (RR 1.11, 95% CI 0.69-1.80) following cholera vaccine administration was found compared with control group. There was also no association with an increased risk of preterm delivery (RR 0.61, 95% CI 0.35-1.06) low birthweight (RR 0.84, 95% CI 0.56- 1.26), accidental abortion (RR 1.02, 95% CI 0.77-1.35) or malformation (RR 0.70, 95% CI 0.22-2.25).
This study shows no evidence of an association between oral cholera vaccination and adverse pregnancy outcomes. The findings do not rigorously exclude the possibility that the vaccine protocol may result in some degree of harm.
There is no evidence of an association between oral cholera vaccination and adverse pregnancy outcomes. The findings do not rigorously exclude the possibility that the vaccine protocol may result in some degree of harm.
霍乱对胎儿有不良影响,但关于孕妇口服霍乱疫苗的安全性数据仍存在争议。
我们首次对比较口服霍乱疫苗接种与未接种孕妇妊娠结局的研究进行了荟萃分析。感兴趣的结局包括不良妊娠结局、流产、死产、早产、低出生体重、堕胎和畸形。
在 MEDLINE/PubMed、SCOPUS 和 Embase 数据库中进行了检索,检索时间从建库至 2019 年 12 月。
纳入标准为:(1)研究口服霍乱疫苗与不良妊娠结局之间关系的研究;(2)报告了具有适当估计值的结局的研究;(3)包含未接种疫苗对照组的研究。
采用随机效应模型(DerSimonian 和 Laird)评估总体治疗效果(相对风险,RR)。本荟萃分析报告遵循 PRISMA 声明。
荟萃分析纳入了 5 项研究,共纳入 5584 名女性(2920 名暴露组,2664 名未暴露组)。与对照组相比,接种霍乱疫苗后不良妊娠结局(RR 1.03,95%CI 0.79-1.34)、流产(RR 1.15,95%CI 0.84-1.57)或死产(RR 1.11,95%CI 0.69-1.80)发生率无显著增加。也没有早产(RR 0.61,95%CI 0.35-1.06)、低出生体重(RR 0.84,95%CI 0.56-1.26)、意外堕胎(RR 1.02,95%CI 0.77-1.35)或畸形(RR 0.70,95%CI 0.22-2.25)风险增加的相关性。
本研究表明,口服霍乱疫苗接种与不良妊娠结局之间无关联。这些发现并不能严格排除疫苗方案可能导致某种程度伤害的可能性。
口服霍乱疫苗接种与不良妊娠结局之间无关联。这些发现并不能严格排除疫苗方案可能导致某种程度伤害的可能性。